A Checklist for Optimizing Clinical Trial Study Startup Activities
From protocol design to site training, optimizing study startup requires meticulous planning and collaboration to ensure timely trial activation.
From protocol design to site training, optimizing study startup requires meticulous planning and collaboration to ensure timely trial activation.
Like every institutional review board (IRB) – commercial or local – Advarra is subject to inspections from time to time.
Advarra expert Steffen Engel answers questions from the recent webinar, Stepwise Implementation of a Clinical Quality Management System. Q: How
Integrating eRegulatory and eIRB systems streamlines document management, enhances compliance, and delivers significant ROI through time and cost savings per protocol.
New to the process of helping to bring a drug to market? As intimidating as the Food and Drug Administration
An incidental finding is a “finding” or result from an intervention or test that uncovers a condition or problem that
Learn the essentials of creating a robust charter for DMCs and EACs—an indispensable tool for clinical trial oversight and regulatory compliance.
In addition to other responsibilities, human subjects protection programs (HRPPs) and IRBs are tasked with ensuring a research protocol’s lifecycle
Advarra’s Site-Sponsor Consortium emphasizes shared standards and transparent dialogue, paving the way for scalable, collaborative research advancements.
This blog outlines some of the critical events where endpoint adjudication committees (EACs) can be used to look at more than just “endpoints” in clinical research.
See how Advarra’s tech-enabled adjudication platform leverages expert collaboration and secure data integration to streamline clinical endpoint evaluation.
In its March 2006 guidance, Establishment and Operations of Clinical Trial Data Monitoring Committees, the U.S. Food and Drug Administration